To explore the mechanism by which Src activation contributes to peritoneal fibrosis, we examined the effect of Src inhibition on the expression of TGF-β receptor I and II as well as the phosphorylation (activation) of Smad3 in the peritoneum after CG injury. This evidence concerns the gene SMAD3 and Peritoneal Fibrosis.